Hikal quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	403	380	+5.9%
EBITDA	37.0	25.1	+47.4%
EBITDA margin	9.2%	6.6%	+2.6 pts
Profit before tax	−9.9	−30.4	—
Net profit	−7.4	−22.4	—
EPS	−₹0.60	−₹1.82	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	403	519	494	319	380	552	448	453	407	514	448	435	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	1.8	6.6	2.8	1.9	1.0	0.5	3.6	0.4	0.5	0.5	0.1	1.0
	405	526	497	320	381	553	451	453	407	515	448	436
	194	210	188	219	182	211	213	224	235	183	193	212
	−11.4	6.3	44.4	−92.4	4.8	21.5	−1.9	−22.4	−42.5	51.1	14.2	0.8
	74.4	67.2	70.6	69.6	62.9	63.4	64.5	62.1	57.1	63.8	61.3	61.8
	14.9	14.6	15.5	14.9	17.1	17.9	18.7	18.8	19.8	15.3	14.2	13.1
	42.7	42.0	41.2	41.2	39.4	37.7	33.2	31.7	31.8	32.3	29.0	28.6
	109	130	109	115	106	133	100	114	99.4	122	115	102
	423	471	468	367	412	485	428	429	400	467	426	419
	37.0	105	82.7	7.2	25.1	123	72.1	74.9	58.0	94.5	64.8	57.5
	−5.7	63.4	41.5	−34.0	−14.3	85.7	38.9	43.2	26.2	62.1	35.8	29.0
Profit
	−18.8	55.4	28.8	−47.0	−30.4	68.3	23.8	24.8	6.9	47.3	21.6	16.9
	8.9	−47.1	−38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−9.9	8.3	−9.2	−47.0	−30.4	68.3	23.8	24.8	6.9	47.3	21.6	16.9
	0.0	−2.0	0.0	0.0	0.0	17.3	4.5	6.7	1.5	16.0	5.2	4.5
	−2.5	−4.1	−3.3	−12.1	−8.0	0.8	2.1	−0.2	0.3	−2.6	0.3	−0.2
	−2.5	−6.1	−3.3	−12.1	−8.0	18.1	6.6	6.5	1.8	13.4	5.5	4.3
	−7.4	14.4	−5.9	−34.9	−22.4	50.2	17.2	18.3	5.1	34.0	16.1	12.6
	−7.4	14.4	−5.9	−34.9	−22.4	50.2	17.2	18.3	5.1	34.0	16.1	12.6
	0.2	−1.6	0.0	−0.4	−0.4	−1.0	−0.1	−0.2	−0.1	−0.2	−0.1	−0.1
	−7.2	12.8	−5.9	−35.3	−22.8	49.2	17.1	18.1	5.0	33.8	16.0	12.4
	—	—	—	—	−22.4	50.2	17.2	18.3	—	34.0	16.1	12.6
Per share
	−₹0.60	₹1.17	−₹0.48	−₹2.83	−₹1.82	₹4.07	₹1.39	₹1.48	₹0.41	₹2.76	₹1.31	₹1.02
	−₹0.60	₹1.17	−₹0.48	−₹2.83	−₹1.82	₹4.07	₹1.39	₹1.48	₹0.41	₹2.76	₹1.31	₹1.02
Other comprehensive income — detail
	0.2	−1.6	0.0	−0.4	−0.4	−1.0	—	—	—	—	—	—
	—	—	0.0	—	−0.5	—	−0.2	—	0.0	−0.3	−0.2	−0.2
	−0.2	2.2	0.0	0.5	−0.1	1.2	—	—	—	—	—	—
	—	—	—	—	—	—	−0.1	0.3	0.2	−0.1	−0.0	−0.1
	0.0	−0.6	0.0	−0.1	0.0	−0.2	—	—	—	—	—	—
	—	—	—	—	—	—	—	−0.1	−0.1	0.0	0.0	0.0
	−7.4	—	—	—	−22.4	50.2	17.2	18.3	—	34.0	16.1	12.6
Per share — as-filed variants
	−₹0.60	₹1.17	−₹0.48	−₹2.83	−₹1.82	₹4.07	₹1.39	₹1.48	₹0.41	₹2.76	₹1.31	₹1.02
	−₹0.60	₹1.17	−₹0.48	−₹2.83	−₹1.82	₹4.07	₹1.39	₹1.48	₹0.41	₹2.76	₹1.31	₹1.02
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	220	303	262	192	194	320	237	251	215	280	241	222
	54.7%	58.3%	53.1%	60.3%	50.9%	58.0%	52.9%	55.4%	52.7%	54.4%	53.8%	51.0%
Adjusted (ex-exceptional items) — derived
	−18.8	55.4	28.8	−47.0	−30.4	68.3	23.8	24.8	6.9	47.3	21.6	16.9
	8.9	−47.1	−38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−14.1	61.5	18.5	−34.9	−22.4	50.2	17.2	18.3	5.1	34.0	16.1	12.6
	−₹1.14	₹5.00	₹1.50	−₹2.83	−₹1.82	₹4.07	₹1.39	₹1.48	₹0.41	₹2.76	₹1.31	₹1.02

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HIKAL₹204.40

Hikal Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersPANACEABIO DCAL SAIPARENT INDOCO SOLARA WINDLAS INDSWFTLAB HESTERBIOMcap ₹2,524 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	434.9	447.6	514.1	406.8	452.9	447.7	552.4	380.4	318.5	494.3	519.4	402.8
Other Income	1.0	0.1	0.5	0.5	0.4	3.6	0.5	1.0	1.9	2.8	6.6	1.8
Total Income	435.9	447.6	514.6	407.3	453.3	451.3	552.9	381.4	320.4	497.1	526.0	404.6
Expenses
+ Cost of Materials Consumed	212.3	192.6	183.2	234.8	224.3	212.8	210.7	182.0	218.7	187.6	210.3	194.0
+ Changes in Inventories	0.8	14.2	51.1	-42.5	-22.4	-1.9	21.5	4.8	-92.4	44.4	6.3	-11.4
+ Employee Benefit Expense	61.8	61.3	63.8	57.1	62.1	64.5	63.4	62.9	69.6	70.6	67.2	74.4
+ Finance Costs	13.1	14.2	15.3	19.8	18.8	18.7	17.9	17.1	14.9	15.5	14.6	14.9
+ Depreciation & Amortisation	28.6	29.0	32.3	31.8	31.7	33.2	37.7	39.4	41.2	41.2	42.0	42.7
+ Other Expenses	102.4	114.7	121.6	99.4	114.0	100.2	133.4	105.6	115.4	109.0	130.2	108.8
Total Expenses	419.0	426.0	467.2	400.4	428.5	427.5	484.6	411.8	367.4	468.3	470.6	423.4
EBITDA	57.5	64.8	94.5	58.0	74.9	72.1	123.4	25.1	7.2	82.7	105.4	37.0
EBIT	29.0	35.8	62.1	26.2	43.2	38.9	85.7	-14.3	-34.0	41.5	63.4	-5.7
Profit
PBT before Exceptional Items	16.9	21.6	47.3	6.9	24.8	23.8	68.3	-30.4	-47.0	28.8	55.4	-18.8
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-38.0	-47.1	8.9
Pretax Income	16.9	21.6	47.3	6.9	24.8	23.8	68.3	-30.4	-47.0	-9.2	8.3	-9.9
+ Current Tax	4.5	5.2	16.0	1.5	6.7	4.5	17.3	0.0	0.0	0.0	-2.0	0.0
+ Deferred Tax	-0.2	0.3	-2.6	0.3	-0.2	2.1	0.8	-8.0	-12.1	-3.3	-4.1	-2.5
Tax Expense	4.3	5.5	13.4	1.8	6.5	6.6	18.1	-8.0	-12.1	-3.3	-6.1	-2.5
Net Income	12.6	16.1	34.0	5.1	18.3	17.2	50.2	-22.4	-34.9	-5.9	14.4	-7.4
+ Net Income — Continuing Ops	12.6	16.1	34.0	5.1	18.3	17.2	50.2	-22.4	-34.9	-5.9	14.4	-7.4
+ Other Comprehensive Income	-0.1	-0.1	-0.2	-0.1	-0.2	-0.1	-1.0	-0.4	-0.4	0.0	-1.6	0.2
Total Comprehensive Income	12.4	16.0	33.8	5.0	18.1	17.1	49.2	-22.8	-35.3	-5.9	12.8	-7.2
Net Income to Common	12.6	16.1	34.0	—	18.3	17.2	50.2	-22.4	—	—	—	—
Per Share
Basic EPS	1.02	1.31	2.76	0.41	1.48	1.39	4.07	-1.82	-2.83	-0.48	1.17	-0.60
Diluted EPS	1.02	1.31	2.76	0.41	1.48	1.39	4.07	-1.82	-2.83	-0.48	1.17	-0.60
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-1.0	-0.4	-0.4	0.0	-1.6	0.2
+ Items NOT to be Reclassified to P&L	-0.2	-0.2	-0.3	0.0	—	-0.2	—	-0.5	—	0.0	—	—
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	1.2	-0.1	0.5	0.0	2.2	-0.2
+ Tax on Items NOT to be Reclassified — alt tag	-0.1	-0.0	-0.1	0.2	0.3	-0.1	—	—	—	—	—	—
+ Tax on Items to be Reclassified	—	—	—	—	—	—	-0.2	0.0	-0.1	0.0	-0.6	0.0
+ Tax on Items to be Reclassified — alt tag	0.0	0.0	0.0	-0.1	-0.1	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	12.6	16.1	34.0	—	18.3	17.2	50.2	-22.4	—	—	—	-7.4
Per Share — as-filed variants
Basic EPS — Continuing Operations	1.02	1.31	2.76	0.41	1.48	1.39	4.07	-1.82	-2.83	-0.48	1.17	-0.60
Diluted EPS — Continuing Operations	1.02	1.31	2.76	0.41	1.48	1.39	4.07	-1.82	-2.83	-0.48	1.17	-0.60
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	221.8	240.8	279.9	214.5	251.0	236.8	320.2	193.6	192.2	262.3	302.8	220.2
Gross Margin %	50.99	53.79	54.43	52.73	55.42	52.89	57.97	50.89	60.35	53.06	58.30	54.67
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	16.9	21.6	47.3	6.9	24.8	23.8	68.3	-30.4	-47.0	28.8	55.4	-18.8
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-38.0	-47.1	8.9
Net Income Adj (tax-effected)	12.6	16.1	34.0	5.1	18.3	17.2	50.2	-22.4	-34.9	18.5	61.5	-14.1
EPS Adj	1.02	1.31	2.76	0.41	1.48	1.39	4.07	-1.82	-2.83	1.50	5.00	-1.14
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Filed Debt Equity	—	—	0.00	—	—	—	0.59	0.54	0.55	0.58	0.56	0.53
Filed Dscr	—	—	0.00	—	—	—	1.45	0.92	1.19	0.95	1.22	1.23
Filed Iscr	—	—	0.00	—	—	—	4.00	7.94	3.36	2.77	3.76	3.82
Paid Up Equity Capital	24.7	24.7	24.7	24.7	24.7	24.7	24.7	24.7	24.7	24.7	24.7	24.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Hikal Q2 FY27 results date

Hikal (NSE: HIKAL) will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, according to the board-meeting notice it filed on 26 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net loss was ₹7.4 crore, narrower than the loss of ₹22.4 crore in Q1 FY26 and against a profit of ₹14.4 crore in Q4 FY26. Revenue from operations was ₹403 crore, up 5.9% year on year and down 22.4% from the previous quarter.

Board-meeting notice filed: 26 October 2026
Q2 FY26 results (a year earlier): 13 April 2026
Q1 FY27 results (the latest): 6 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 3 November 2026Tuesday · notice filed 26 Oct
Q1 FY27 net loss: −₹7.4 Crloss ₹22.4 Cr in Q1 FY26profit ₹14.4 Cr in Q4 FY26
Q1 FY27 revenue: ₹403 Cr+5.9% vs Q1 FY26−22.4% vs Q4 FY26
Q1 FY27 operating margin: −1.4%+2.3 pts vs Q1 FY26−13.6 pts vs Q4 FY26
Q2 FY26 net loss (a year earlier): −₹34.9 CrRevenue ₹319 Cr
Q1 FY27 EPS (basic): −₹0.60

Questions

When will Hikal announce its Q2 FY27 results?

On 3 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 26 October 2026). Last year it reported Q2 FY26 on 13 April 2026.

What were Hikal's Q1 FY27 results?

Consolidated net loss was ₹7.4 crore, narrower than the loss of ₹22.4 crore in Q1 FY26 and against a profit of ₹14.4 crore in Q4 FY26. Revenue from operations was ₹403 crore, up 5.9% year on year and down 22.4% from the previous quarter.

What was Hikal's net profit in FY26?

Consolidated net profit was a loss of ₹48.8 crore in FY26 (April 2025–March 2026), against a profit of ₹90.8 crore in FY25. It was a profit of ₹69.6 crore in FY24 and a profit of ₹78.4 crore in FY23.

What will Hikal's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net loss was ₹34.9 crore and revenue from operations ₹319 crore. The latest quarter, Q1 FY27, had a net loss of ₹7.4 crore and revenue of ₹403 crore.

How has Hikal's profit changed over the last four quarters?

Net profit by quarter: a loss of ₹34.9 crore in Q2 FY26, a loss of ₹5.9 crore in Q3 FY26, a profit of ₹14.4 crore in Q4 FY26 and a loss of ₹7.4 crore in Q1 FY27. That is a combined loss of ₹33.8 crore over the four quarters. Revenue from operations: ₹319 crore, ₹494 crore, ₹519 crore and ₹403 crore.

What was Hikal's revenue in FY26?

Revenue from operations was ₹1,713 crore in FY26 (April 2025–March 2026), down 7.9% from ₹1,860 crore in FY25. It was ₹1,785 crore in FY24 and ₹2,023 crore in FY23: down 15.3% over three years, an average fall of 5.4% a year.

Where do these Hikal figures come from?

From Hikal's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.